Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Improved Survival With Enzalutamide in Patients With Metastatic Hormone-Sensitive Prostate CancerJ. Clin. Oncol 2022 Apr 14;[EPub Ahead of Print], AJ Armstrong, AA Azad, T Iguchi, RZ Szmulewitz, DP Petrylak, J Holzbeierlein, A Villers, A Alcaraz, B Alekseev, ND Shore, F Gomez-Veiga, B Rosbrook, F Zohren, S Yamada, GP Haas, A Stenzl
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Advanced Prostate Cancer Center of Excellence
Visit our Advanced Prostate Cancer Center of Excellence for additional, in-depth coverage.